PROMETRIKA A Full-Service CRO
Follow Us
  • Home

THOUGHT LEADERSHIP

Recent Posts

  • The Investigator Responsibilities in IND Safety Reporting
  • The Sponsor’s Responsibilities in IND Safety Reporting
  • Checklists Can be a Piece of Cake
  • CDISC SDTM Certification
  • Adaptive Design Options for Dose Finding Trials
  • Search

      Search

  • About

      About

    • Overview
    • Management Team
    • News Highlights
    • Video Library
    • Conferences & Events
    • Giving Back to Community
  • Experience

      Experience

    • Overview
    • Therapeutic Areas
    • Phase
    • Rare Diseases
    • Oncology
    • NDA & MAA Regulatory Submissions
    • Rescue Projects
    • Publications
    • Presentations
  • Services

      Services

    • Overview
    • Clinical Operations & Regulatory Affairs
    • Data Management
    • Biostatistics & Programming
    • Medical & Regulatory Writing
    • Pharmacovigilance
    • Full Service
    • Functional Services
    • Consulting Services
    • Specialized Services
      • NDA & MAA Submissions
      • Adaptive Design
      • IDMC Services
      • CDISC SDTM & ADaM
      • Protocol Development
      • Post Marketing
  • Technology
  • Thought Leadership
  • Careers
  • Contact

      Contact

    • Contact Information
    • Directions
  • Search

      Search

  • About

      About

    • Overview
    • Management Team
    • News Highlights
    • Video Library
    • Conferences & Events
    • Giving Back to Community
  • Experience

      Experience

    • Overview
    • Therapeutic Areas
    • Phase
    • Rare Diseases
    • Oncology
    • NDA & MAA Regulatory Submissions
    • Rescue Projects
    • Publications
    • Presentations
  • Services

      Services

    • Overview
    • Clinical Operations & Regulatory Affairs
    • Data Management
    • Biostatistics & Programming
    • Medical & Regulatory Writing
    • Pharmacovigilance
    • Full Service
    • Functional Services
    • Consulting Services
    • Specialized Services
      • NDA & MAA Submissions
      • Adaptive Design
      • IDMC Services
      • CDISC SDTM & ADaM
      • Protocol Development
      • Post Marketing
  • Technology
  • Thought Leadership
  • Careers
  • Contact

      Contact

    • Contact Information
    • Directions
  • January 12 2021 Jen Wind, MA, PMP

    Rampant Misuse of the Word “De-Identified”

    Having worked in the world of clinical research for 15 years, I can’t help but be baffled by the rampant misuse of the word “de-identified” as it relates to the classification of clinical data sets.  In the United States, “the HIPAA Privacy Rule provides federal protections for personal health information [PHI] held by covered entities and gives patients an array of rights with respect to that information.”  De-identified health information is not PHI and thus is not protected by HIPAA.

    It’s a common misconception that if you remove patients’ names from a set of clinical data, then it becomes de-identified and is no longer governed by HIPAA.  However, to make a set of clinical data truly de-identified, you must remove much more than just the patients’ names. 

    • Clinical Data Management
    • Data Sets
    • Clinical Research
    Continue Reading
  • December 8 2020 Chelsey Ryan, PMP

    Putting Patients First: Taking Trials and Technology Home

    Home visits as part of clinical research have accelerated in recent years as we strive to find the right balance between facilitating study participation while accommodating participant’s busy everyday lives. Clinical trials in rare diseases are even more challenging than trials in other diseases due to a number of factors:

    • Small number of eligible trial participants
    • Complicated by heterogeneity among rare disease patients
    • Most have no cure and manifest at a young age
    • Less than 10% of rare diseases have a specific treatment
    • Many have other debilitating conditions / physical limitations making it difficult to attend frequent study visits

    The combination of home study visits and the right technology removes barriers to optimal patient recruitment, compliance and retention.

    • 4Patients
    • Collaboration
    • Technology
    • Critical Data
    • Global Clinical Trials
    • Gaining Efficiencies
    • Clinical Operations
    • Rare Disease
    Continue Reading
  • November 5 2020 Nicole LaVallee, PhD

    Tipping Point Analyses in Missing Data Imputation

    This is the last in a series of three posts on missing data imputation.  In the first post, we reviewed the underlying assumptions and limitations of single imputation methods, in particular, last observation carried forward (LOCF).  In the second post, we considered more sophisticated data imputation methods for longitudinal data, Mixed Models for Repeated Measures (MMRM) and Multiple Imputation (MI).  An important assumption for both MMRM and MI is that the data are ‘missing at random’ (MAR), if not ‘missing completely at random’ (MCAR).  But what if this assumption is not true for all the missing data?

    • Stats For Life
    • DataScience
    • Biostatistics
    • Mathematics
    • Statisticians
    Continue Reading
  • October 7 2020 Alicia Ross, RN, BSN

    A thought provoking discussion by leading experts on review, accessibility and monitoring of COVID-19 Vaccines

    Four former FDA commissioners and Dr. Peter Marks, the FDA official responsible for the oversight of vaccines, shared their thoughts on the FDA’s role in ensuring the safety and effectiveness of COVID-19 vaccines under extraordinary circumstances, in the ongoing pandemic.

    The event, entitled “Safe and Effective COVID-19 Vaccination: The Path from Here” was hosted by the Duke-Margolis Center for Health Policy on September 10, 2020.  The speakers discussed the mountain of challenges across all aspects of developing and distributing a vaccine under expedited timelines: testing, reviewing, approving, monitoring safety events, and the logistics of distribution for vaccines that may require specialized storage conditions.

    • FDA
    • Safety
    • COVID-19
    • Vaccines
    • Pandemic
    Continue Reading
  • September 14 2020 Cathy Hult

    Invest in Your Laboratory Information Success

    All clinical data managers (CDMs) are familiar with the difficulties of ensuring that laboratory values are compared to the local laboratory normal ranges that were valid at the time of the measurement. In studies with many local laboratories, and in global studies, the same test may be reported in different units across the study. To help alleviate these problems, some studies use central laboratories. Yet there are some problems with this approach as well. Shipping samples from study sites to the central laboratory incurs extra cost and runs the risk that the sample will be unusable when it arrives. 

    • Medidata
    • Laboratory
    • Critical Data
    • Data Standards
    • Data Management
    • Gaining Efficiencies
    Continue Reading
  • Prev
  • 1
  • …
  • 3
  • 4
  • 5
  • …
  • 16
  • Next

TOPICS

  • 4Patients
  • ADaM
  • AICROS
  • Analytics
  • Angelman Syndrome
  • Approval
  • Bayesian
  • BIMO
  • Biostatistics
  • Biotech
  • BOIN
  • Cancer
  • CDASH
  • CDISC
  • Certification
  • Checklist
  • Clinical Data Management
  • Clinical Operations
  • Clinical Operations Services
  • Clinical Research
  • Clinical Research Organization
  • Clinical Tools
  • Clinical Trials
  • Clinical Trials
  • Close-out
  • Collaboration
  • COVID-19
  • CRA
  • Critical Data
  • CRO
  • Data Analytics
  • Data Management
  • Data Sets
  • Data Standards
  • DataScience
  • Descriptive Analytics
  • DIA
  • DIA Reference Model
  • Drug Development Innovations
  • Drug Safety
  • Education
  • electronic trial master file
  • eTMF
  • Events
  • FDA
  • Full-service CRO
  • Gaining Efficiencies
  • Giving Back
  • Global Clinical Trials
  • Globalization
  • ICHE8
  • Immunotherapy
  • IND
  • Interchange
  • ISE
  • ISS
  • Laboratory
  • Life Sciences
  • MAA
  • MassBio
  • Mathematics
  • Maximum tolerated dose
  • Medical Imaging
  • Medical Writers
  • Medical Writing
  • Medidata
  • MTD
  • mTPI
  • Multicountry
  • Natural History Study
  • NDA
  • Oncology
  • Pandemic
  • Pharma
  • Pharmacovigilance
  • Philanthropy
  • Productivity
  • Project Management
  • Quality Chat
  • Rare Disease
  • RBM
  • RBQM
  • RCT
  • Regulatory
  • Regulatory Writing
  • SAE
  • Safety
  • SAP
  • SDR
  • SDTM
  • SDV
  • Site Engagement
  • Software
  • Source Data Review
  • Source Data Verification
  • Stakeholder Analysis
  • Startup
  • Statisticians
  • Stats For Life
  • Technology
  • Telehealth
  • TMF
  • Treatment
  • Trial Master File
  • Vaccines
  • Visualizations

ARCHIVE

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
RSS

Recent Posts

  • The Investigator Responsibilities in IND Safety Reporting
  • The Sponsor’s Responsibilities in IND Safety Reporting
  • Checklists Can be a Piece of Cake
  • CDISC SDTM Certification
  • Adaptive Design Options for Dose Finding Trials
HOW CAN WE HELP?
Contact PROMETRIKA today to get started.
Contact Us

Site Map

  • Home
  • About
    • Overview
    • Management Team
    • News Highlights
    • Video Library
    • Conferences & Events
    • Giving Back to Community
  • Experience
    • Overview
    • Therapeutic Areas
    • Phase
    • Rare Diseases
    • Oncology
    • NDA & MAA Regulatory Submissions
    • Rescue Projects
    • Publications
    • Presentations
  • Services
    • Overview
    • Clinical Operations & Regulatory Affairs
    • Data Management
    • Biostatistics & Programming
    • Medical & Regulatory Writing
    • Pharmacovigilance
    • Full Service
    • Functional Services
    • Consulting Services
    • Specialized Services
  • Technology
  • Thought Leadership
  • Careers
  • Contact
    • Contact Information
    • Directions
designed by
Solution Innovators Logo
PROMETRIKA, LLC
100 CambridgePark Drive, 2nd Floor
Cambridge, MA 02140
617.868.2020
  • Privacy Policy |
  • Careers |
  • Login
  • Certified Women's Business Enterprise
  • Medidata Services Provider
  • CDISC
  • AICROS
PROMETRIKA
© 2022 PROMETRIKA, LLC. All rights reserved.
designed by
Solution Innovators Logo